NCT02125838

Brief Summary

Laryngeal mask (LM) use in gynecological laparoscopy, contrary to widespread opinion, does not increase the incidence of gastric aspiration, the failure of ventilation or the risk of pulmonary aspiration . LM is presented as an alternative to endo tracheal tube (ETT) in spontaneous or positive pressure ventilation (PPV) . LM has gained widespread popularity in England for gynecological laparoscopic procedures. In addition in many previous studies LM has been successfully shown to provide appropriate lung ventilation in laparoscopic surgical interventions .Miller et al. compared the use of ETT, LM-P laparoscopic gynecological interventions and identified advantages to LM use. The most important of these advantages was that, contrary to tracheal tube techniques for laparoscopic surgeries, use of supraglottic laryngeal devices or neuromuscular blocker agents (NBA) were not required during placement. Thus for laparoscopic surgeries, compared with the ETT technique, without the need for supraglottic laryngeal devices or muscular relaxants, it is easily placed and reduces the time spent in the operating room. Our aim; to compare the use of LM-S and ETT without neuromuscular agents for laparoscopic gynecological intervention with positive pressure ventilation from a surgical viewpoint and in terms of effect on ventilation parameters. Secondary aim, comparison of airway morbidity with endotracheal intubation and supraglottic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 31, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 29, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
2 years until next milestone

Results Posted

Study results publicly available

March 28, 2017

Completed
Last Updated

March 28, 2017

Status Verified

February 1, 2017

Enrollment Period

1.8 years

First QC Date

January 31, 2014

Results QC Date

August 30, 2015

Last Update Submit

February 8, 2017

Conditions

Keywords

laryngeal mask Supremelaparoscopic gynecologic surgeryLaryngeal mask during surgery

Outcome Measures

Primary Outcomes (3)

  • Asses to Ventilation Parameters

    tidal volume (ml) at certain time intervals T1= 2 minutes after airway device insertion T2= 10 minutes after insufflation T3= Before desufflation T4= Before removal of airway device

    intraoperative period

  • Asses to Peak Pressure

    peak pressure (cmH20) at certain time intervals T1= 2 minutes after airway device insertion T2= 10 minutes after insufflation T3= Before desufflation T4= Before removal of airway device

    intraoperative period

  • Asses to Mean Pressure

    mean pressures within the times below (cmH20) T1= 2 minutes after airway device insertion T2= 10 minutes after insufflation T3= Before desufflation T4= Before removal of airway device

    during procedure

Secondary Outcomes (5)

  • Quality of View According to Surgeon by Rate Scale

    intraoperative period

  • Evaluation of Gastric Distention

    Baseline

  • Ease of Orogastric Tube Placement Classification

    Baseline

  • Haemodynamic Response to Insertion of Airway Device

    Baseline

  • Incidence of Post-operative Sore Throat

    Baseline

Study Arms (2)

Group ETT

ACTIVE COMPARATOR

Group endotracheal tube In the endotracheal tube group for women no. 7-7.5 tube will use. ETT:Rüschelit, Teleflex Medical Sdn. Bhd. Malaysia. Ref:112482

Device: Endotracheal Tube

Group LMS

EXPERIMENTAL

Laryngeal mask airway-supreme Group In the LMS group for \<50 kg, no. 3 Between 50-70 kg, no. 4 Between 70-100 kg, no. 5 LM-S (The Laryngeal Mask Company Limited, Singapore) will insert.

Device: Laryngeal Mask Airway-Supreme

Interventions

Group LM-S (Laryngeal Mask Airway-Supreme)Before LM-S was inserted, to lubricate the surface in contact with the palate a water-based gel without local anesthetic was applied to completely cover the LM-S cuff. Depending on the patient's body weight For \<50 kg, no. 3 Between 50-70 kg, no. 4 Between 70-100 kg, no. 5 LM-S (The Laryngeal Mask Company Limited, Singapore) was inserted.

Also known as: Group LM-S
Group LMS

ETT

Also known as: Group ETT
Group ETT

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA classification group I-II
  • Between 18-65 years
  • Undergoing elective laparoscopic gynecological surgery

You may not qualify if:

  • Individuals with any neck and upper respiratory pathology
  • Individuals at risk of gastric content regurgitation/aspiration (previous upper gastrointestinal surgery, known hiatus hernia, gastroesophageal reflux, history of peptic ulcer, full stomach, pregnancy)
  • Individuals with low pulmonary compliance or high airway resistance (chronic lung diseases)
  • Obese patients (BMI \>35)
  • Individuals with sore throat, dysphagia and dysphonia
  • Individuals with possibility or history of difficult airway
  • Operation time planned for more than 4 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sule Ozbilgin

Izmi̇r, Narlıdere, 35320, Turkey (Türkiye)

Location

Results Point of Contact

Title
Sule Ozbilgin
Organization
DorkuzEU

Study Officials

  • SULE OZBİLİGİN, M.D.

    STUDY DESİGN

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anaesthesiology and Reanimation

Study Record Dates

First Submitted

January 31, 2014

First Posted

April 29, 2014

Study Start

May 1, 2013

Primary Completion

March 1, 2015

Study Completion

April 1, 2015

Last Updated

March 28, 2017

Results First Posted

March 28, 2017

Record last verified: 2017-02

Locations